日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Overcoming Ligand Discovery Challenges: Developing Peptide-Based Tracers for SPSB2

克服配体发现挑战:开发用于 SPSB2 的基于肽的示踪剂

Lenz, Christopher; Elson, Lewis; Dopfer, Johannes; Farges, Frederic; Krämer, Andreas; Löhr, Frank; Müller, Susanne; Guéret, Stéphanie M; Waldmann, Herbert; Dötsch, Volker; Saxena, Krishna; Knapp, Stefan

New Quinoline Kinase Inhibitors With Good Selectivity for NAK Kinases and Anti-Tumor Activity Against Ewing Sarcoma

新型喹啉激酶抑制剂对NAK激酶具有良好的选择性,并对尤文氏肉瘤具有抗肿瘤活性

Gentz, Caroline de Bem; Fernandes, Thais Helena Maciel; Lopes, Marcela Silva; Elson, Lewis; Krämer, Andreas; Souza, Lucas Rodrigo de; Fortes, Isadora Serraglio; Pinto, Geórgia Silva; Martins, Martha Cestari Silva; Lima, Henrique Barros de; Santiago, André da Silva; Gregianin, Lauro José; Massirer, Katlin Brauer; Bengtson, Mário Henrique; Roesler, Rafael; Knapp, Stefan; Laufer, Stefan A; Andrade, Saulo Fernandes de

Un-LOK-ing a New Approach for Conformational Selective Targeting of STK10 (LOK)

针对 STK10 (LOK) 构象选择性靶向的新方法——解构 LOK

Dettenhöfer, Martina; Tandara, Laura Nadine; Amrhein, Jennifer Alisa; Kurz, Christian Georg; Schwalm, Martin Peter; Mensing, Theresa Elisabeth; Wahl, Laurenz Maximilian; Krämer, Andreas; Gerninghaus, Joshua; Lenz, Christopher; Elson, Lewis; Berger, Benedict-Tilman; Schröder, Martin; Saxena, Krishna; Müller, Susanne; Knapp, Stefan; Greco, Francesco Aleksy; Hanke, Thomas

Workflow for E3 Ligase Ligand Validation for PROTAC Development

PROTAC 开发中 E3 连接酶配体验证的工作流程

Miletić, Nebojša; Weckesser, Janik; Mosler, Thorsten; Rathore, Rajeshwari; Hoffmann, Marina E; Gehrtz, Paul; Schlesiger, Sarah; Hartung, Ingo V; Berner, Nicola; Wilhelm, Stephanie; Müller, Juliane; Adhikari, Bikash; Němec, Václav; Sivashanmugam, Saran Aswathaman; Elson, Lewis; Holzmann, Hanna; Schwalm, Martin P; Hoffmann, Lasse; Abdul Azeez, Kamal Rayees; Müller, Susanne; Kuster, Bernhard; Wolf, Elmar; Đikić, Ivan; Knapp, Stefan

Functional Characterization of Pathway Inhibitors for the Ubiquitin-Proteasome System (UPS) as Tool Compounds for CRBN and VHL-Mediated Targeted Protein Degradation.

泛素-蛋白酶体系统 (UPS) 通路抑制剂的功能表征,作为 CRBN 和 VHL 介导的靶向蛋白质降解的工具化合物

Schwalm Martin P, Menge Amelie, Elson Lewis, Greco Francesco A, Robers Matthew B, Müller Susanne, Knapp Stefan

Repurposing of the RIPK1-Selective Benzo[1,4]oxazepin-4-one Scaffold for the Development of a Type III LIMK1/2 Inhibitor.

RIPK1 选择性苯并[1,4]氧氮杂环庚酮-4-酮骨架的再利用,用于开发 III 型 LIMK1/2 抑制剂

Mandel Sebastian, Hanke Thomas, Mathea Sebastian, Chatterjee Deep, Saraswati Hayuningbudi, Berger Benedict-Tilman, Schwalm Martin Peter, Yamamoto Satoshi, Tawada Michiko, Takagi Terufumi, Ahmed Mahmood, Röhm Sandra, Corrionero Ana, Alfonso Patricia, Baena Maria, Elson Lewis, Menge Amelie, Krämer Andreas, Pereira Raquel, Müller Susanne, Krause Daniela S, Knapp Stefan

Back-Pocket Optimization of 2-Aminopyrimidine-Based Macrocycles Leads to Potent EPHA2/GAK Kinase Inhibitors.

2-氨基嘧啶基大环化合物的后口袋优化可得到强效的EPHA2/GAK激酶抑制剂

Gerninghaus Joshua, Zhubi Rezart, Krämer Andreas, Karim Marwah, Tran Do Hoang Nhu, Joerger Andreas C, Schreiber Christian, Berger Lena M, Berger Benedict-Tilman, Ehret Theresa A L, Elson Lewis, Lenz Christopher, Saxena Krishna, Müller Susanne, Einav Shirit, Knapp Stefan, Hanke Thomas